Nurix Therapeutics
NRIX
NRIX
118 hedge funds and large institutions have $561M invested in Nurix Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 8 closing their positions.
Holders
118
Holders Change
+12
Holders Change %
+11.32%
% of All Funds
2.04%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
51
Reduced
23
Closed
8
Calls
$1.74M
Puts
$1K
Net Calls
+$1.74M
Net Calls Change
-$400K
Top Buyers
1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$16.8M |
2 |
2
Goldman Sachs
New York
|
$10.8M |
3 |
WA
3
Wasatch Advisors
Salt Lake City,
Utah
|
$34.6M |
4 |
4
BlackRock
New York
|
$48.5M |
5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$7.2M |